“PeriBeam®” was exhibited at the 55th Annual Meeting of the Japanese Society for Cardiovascular Surgery (Thursday, February 20th to Saturday, February 22nd, 2025).
Our Medical Devices Development Pipeline has been updated.
The number of clinical uses of “DuraBeam®”, the artificial dura mater, has exceeded 3,000 cases.
TamaBio has obtained patents for Regenerative Medical Devices : Nerve Damage Repair Sheet, Brain Tissue Damage Repair Sheet and Spinal Cord Injury Repair Sheet.
The joint research period with Tohoku University has been extended.
We will be a sponsor and exhibit at the The 34th Conference on Neurosurgical Techniques and Tools (CNTT2025; Osaka International Convention Center, April 18th (Fri) to 19th (Sat), 2025).
TamaBio will be exhibiting the pericardial membrane PeriBeam® at the 77th Annual Scientific Meeting of the Japanese Association for Thoracic Surgery (at Kanazawa City, Ishikawa Japan).
ISO13485:2016 was maintained : based on the evaluation from the regular audit.
The sterilization expiration date of the Dura Mater Substitute “DuraBeam®” has been extended to three (3) years.
We will be sponsoring the 48th Japanese Society of Neurotraumatology (Feb.21st (Fri) – Feb.22nd (Sat), 2025).
